India’s pharma industry sees hope after US, Iran agree to end war
The US‑Iran peace deal would ease geopolitical tensions, stabilize supply chains, and lower input costs, said Rajiv Nath, forum coordinator of All Indian Medical Devices Manufacturers (Amied). “While immediate relief may be modest, the long‑term benefits will unfold gradually—boosting investor confidence, reducing trade barriers, and creating a more predictable environment for supply chain and logistics costs, innovation and growth,” Nath added.
Post Comment